| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 14.4k | $23.29 | $335.7k | | 06/08/2023 |
| 06/06/2023 | Third Harmonic Bio, Inc. | | Grant | Stock Option (right to buy) | 16.2k | $5.03 | $81.7k | | 06/06/2023 |
| 06/06/2023 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 12.5k | $16.30 | $203.8k | | 06/06/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 6.1k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 15.5k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2.3k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 71.7k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 5.4k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 7.6k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 12.2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 1.6k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 4.6k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 9.2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 7.3k | $0.00 | $0 | | 05/31/2023 |
| 03/14/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (Right to Buy) | 1.5k | $68.50 | $103.6k | | 03/14/2023 |
| 03/06/2023 | Third Harmonic Bio, Inc. | | Grant | Employee Stock Option (right to buy) | 13.7k | $4.20 | $57.4k | | 03/06/2023 |
| 03/06/2023 | Third Harmonic Bio, Inc. | | Disposition | Employee Stock Option (right to buy) | 13.7k | $17.83 | $243.7k | | 03/06/2023 |
| 03/06/2023 | Third Harmonic Bio, Inc. | | Grant | Employee Stock Option (right to buy) | 35.4k | $4.20 | $148.7k | | 03/06/2023 |
| 03/06/2023 | Third Harmonic Bio, Inc. | | Disposition | Employee Stock Option (right to buy) | 35.4k | $9.22 | $326.5k | | 03/06/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 198 | $28.54 | $5.7k | | 01/04/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 41.7k | $0.00 | $0 | | 01/04/2023 |
| 10/26/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 561 | $6.52 | $3.7k | | 10/26/2022 |
| 06/27/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 8k | $0.37 | $3k | | 06/27/2022 |
| 06/21/2022 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 12.5k | $12.26 | $153.2k | | 06/21/2022 |
| 06/02/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 15k | $8.13 | $122k | | 06/02/2022 |
| 05/31/2022 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 16.6k | $18.56 | $308.2k | | 05/31/2022 |
| 01/04/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 9.5k | $1.30 | $12.4k | | 01/03/2022 |
| 01/03/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 775k | $1.37 | $1.1M | | 01/03/2022 |
| 10/26/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 27.6k | $1.80 | $49.7k | | 10/26/2021 |
| 06/29/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 42.2k | $14.00 | $590.8k | | 04/02/2021 |
| 06/28/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 7.6k | $5.77 | $43.8k | | 06/28/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $26.32 | $342.2k | | 06/01/2021 |
| 05/28/2021 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 6.1k | $21.15 | $129.4k | | 05/28/2021 |
| 04/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 39.6k | $0.00 | $0 | | 04/02/2021 |
| 04/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 76.7k | $0.00 | $0 | | 04/02/2021 |
|